Bayesian Capital Management, LP - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$283,496
+31.0%
11,837
+2.9%
0.03%
+11.1%
Q1 2023$216,430
-63.1%
11,500
-72.4%
0.03%
-75.2%
Q2 2022$587,000
+132.9%
41,696
+606.7%
0.11%
+153.5%
Q4 2019$252,000
-73.9%
5,900
-76.9%
0.04%
-81.3%
Q3 2017$964,000
+125.8%
25,584
+72.9%
0.23%
+117.0%
Q4 2016$427,00014,8000.11%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sio Capital Management, LLC 563,200$16,243,0009.48%
Avoro Capital Advisors LLC 1,486,460$42,870,0008.66%
Baker Brothers Advisors 25,819,768$744,642,0007.30%
SECTORAL ASSET MANAGEMENT INC 1,176,543$33,932,0003.76%
HARVEY CAPITAL MANAGEMENT INC 251,825$7,262,0003.38%
ACUTA CAPITAL PARTNERS, LLC 300,000$8,652,0003.22%
Palo Alto Investors LP 1,532,030$44,184,0002.52%
Ghost Tree Capital, LLC 350,000$10,094,0002.43%
EMORY UNIVERSITY 76,121$2,195,0002.16%
WEATHERBIE CAPITAL, LLC 576,784$16,634,0002.09%
View complete list of ACADIA PHARMACEUTICALS INC shareholders